Pioneering a Global Cure for Chronic Hepatitis C Virus Infection.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 27634325.
- Also identified by DOI 10.1016/j.cell.2016.08.038.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This year's Lasker∼Debakey Clinical Medical Research Award honors Ralf Bartenschlager, Charles Rice, and Michael Sofia, pioneers in the development of curative and safe therapies for the 170 million people with hepatitis C virus infection.
Medical subject headings
- Awards and Prizes
- Clinical Medicine
- Hepacivirus
- Hepatitis C, Chronic